Long-term outcome of mesna, ifosfamide, mitoxantrone, etoposide (MINE) regimen as a consolidation in patients with aggressive non-Hodgkin lymphoma responding to CHOP

Author： Dincol Dilek   Buyukcelik Abdullah   Dogan Mutlu   Akbulut Hakan   Samur Mustafa   Demirkazik Ahmet   Senler Filiz   Onur Handan   Icli Fikri  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.27, Iss.3, 2010-09, pp. : 942-945

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term results of a multicentre randomised, comparative phase III trial of CHOP versus CNOP regimens in patients with intermediate-and high-grade non-Hodgkin's lymphomas

By Bezwoda W.   Rastogi R.B.   Erazo Valla A.   Diaz-Maqueo J.C.   Pavlovsky S.   Morioka H.   Resegotti L.   Rueckle H.   Somoza N.   Moreno-Nogueira J.A.   Bernasconi C.   Ho A.   Burns I.   Lardinois J.   van der Merwe A.   Richards E.   Novantrone International Study Group  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 903-911

Elsevier

Access to resources Recommend Favorite

Parental longevity and prognosis in elderly patients with aggressive non-hodgkin's lymphoma

By Ösby Eva   Askling Johan   Landgren Ola   Dickman Paul   Ekbom Anders   Björkholm Magnus  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 297-301

Informa Healthcare

Access to resources Recommend Favorite

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin's lymphoma

By Wang Wenwu  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 107-110

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of adjuvant low-dose total body irradiation in non-hodgkin's lymphoma patients following standard CHOP

By Safwat Akmal   Bayoumi Yasser   Akkoush Hany   Mahmoud Hossam  

Acta Oncologica, Vol. 43, Iss. 5, 2004-07 ,pp. : 480-485

Informa Healthcare

Access to resources Recommend Favorite

Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

By Mey Ulrich   Orlopp Katjana   Flieger Dimitri   Strehl John   Ho Anthony   Hensel Manfred   Bopp Cordula   Gorschlüter Marcus   Wilhelm Martin   Birkmann Josef   Kaiser Ulrich   Neubauer Andreas   Florschütz Axel   Rabe Christian   Hahn Corinna   Glasmacher Axel   Schmidt-Wolf Ingo  

Cancer Investigation, Vol. 24, Iss. 6, 2006-09 ,pp. : 593-600

Informa Healthcare

Access to resources Recommend Favorite